Examining Tenet Healthcare Corp (THC) more closely is necessary

Cameron Mitchell

While Tenet Healthcare Corp has overperformed by 2.68%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, THC rose by 60.03%, with highs and lows ranging from $199.99 to $109.82, whereas the simple moving average jumped by 33.36% in the last 200 days.

On July 28, 2025, Wolfe Research Downgraded Tenet Healthcare Corp (NYSE: THC) to Peer Perform. A report published by Wells Fargo on May 29, 2025, Upgraded its rating to ‘Overweight’ for THC. Robert W. Baird also Downgraded THC shares as ‘Neutral’, setting a target price of $137 on the company’s shares in a report dated April 15, 2025. Morgan Stanley Initiated an Overweight rating on March 26, 2025, and assigned a price target of $165. TD Cowen initiated its ‘Buy’ rating for THC, as published in its report on February 26, 2025. JP Morgan’s report from December 17, 2024 suggests a price prediction of $175 for THC shares, giving the stock a ‘Overweight’ rating. Goldman also rated the stock as ‘Neutral’.

Analysis of Tenet Healthcare Corp (THC)

Further, the quarter-over-quarter increase in sales is 3.29%, showing a positive trend in the upcoming months.

One of the most important indicators of Tenet Healthcare Corp’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. The goal here is to ensure that your current return on equity of 41.09% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 1.63, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.

For any stock, average volume can also provide valuable insight into volatility, and THC is recording 1.32M average volume. On a monthly basis, the volatility of the stock is set at 2.94%, whereas on a weekly basis, it is put at 2.86%, with a gain of 6.24% over the past seven days. Furthermore, long-term investors anticipate a median target price of $202.86, showing growth from the present price of $202.0, which can serve as yet another indication of whether THC is worth investing in or should be passed over.

How Do You Analyze Tenet Healthcare Corp Shares?

The Medical Care Facilities market is dominated by Tenet Healthcare Corp (THC) based in the USA. When comparing Tenet Healthcare Corp shares with other companies under Healthcare, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 12.93, there is a growth in quarterly earnings of 18.80%.

Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 1.22%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 98.15% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.

US Post News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.